Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NERV Minerva Neurosciences

盘后交易 12-23 19:19:11 EST

4.06

+0.08

+2.01%

盘后3.90

-0.16-3.94%

17:19 EST

最高4.07	最低3.88	成交量3.07万
今开3.91	昨收3.98	日振幅4.77%
总市值2,839万	流通市值2,207万	总股本699.34万
成交额12.32万	换手率0.57%	流通股本543.70万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NERV","market":"US","secType":"STK","nameCN":"Minerva Neurosciences","latestPrice":4.06,"timestamp":1766523600000,"preClose":3.98,"halted":0,"volume":30735,"hourTrading":{"tag":"盘后","latestPrice":3.9,"preClose":4.06,"latestTime":"17:19 EST","volume":88,"amount":352.47999599999997,"timestamp":1766528396363},"delay":0,"floatShares":5437017,"shares":6993406,"eps":-1.853295,"marketStatus":"盘后交易","change":0.08,"latestTime":"12-23 19:19:11 EST","open":3.91,"high":4.07,"low":3.88,"amount":123238.99008,"amplitude":0.047739,"askPrice":4.08,"askSize":142,"bidPrice":3.81,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-1.853295,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766538000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1404187200000,"exchange":"NASDAQ","adjPreClose":3.98,"postHourTrading":{"tag":"盘后","latestPrice":3.9,"preClose":4.06,"latestTime":"17:19 EST","volume":88,"amount":352.47999599999997,"timestamp":1766528396363},"volumeRatio":1.036957,"impliedVol":4.114,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/NERV","defaultTab":"news","newsList":[{"id":"1194783703","title":"Minerva Neurosciences：研发及管理成本可能上升，但我们有良好条件为Roluperidone在美国的第三阶段、NDA重新提交与上市准备提供资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1194783703","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194783703?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:36","pubTimestamp":1762346184,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences：研发及管理成本可能上升，但我们有良好条件为Roluperidone在美国的第三阶段、NDA重新提交与上市准备提供资金","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"1144077866","title":"Minerva Neurosciences：推动Roluperidone治疗精神分裂症负面症状的前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1144077866","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144077866?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:32","pubTimestamp":1762345934,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences：推动Roluperidone治疗精神分裂症负面症状的前景","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2577322533","title":"Minerva Neurosciences, Inc盘中异动 大幅下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577322533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577322533?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:30","pubTimestamp":1761226224,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时30分，Minerva Neurosciences, Inc股票出现波动，股价急速下跌5.20%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ventyx Biosciences, Inc.、Ethzilla Corporation C/Wts 06/11/2025、Ibio, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ventyx Biosciences, Inc.、Ibio, Inc.较为活跃，换手率分别为145.33%、70.98%、57.46%，振幅较大的相关个股有Ventyx Biosciences, Inc.、Entero Therapeutics Inc.、Tango Therapeutics, Inc.，振幅分别为8.03%、7.08%、6.87%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321302594d9d1a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321302594d9d1a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":1},{"id":"1138956005","title":"Minerva Neurosciences股价在公司获得高达2亿美元的私人配售后大幅上涨，涨幅达163.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138956005","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138956005?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:38","pubTimestamp":1761053890,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences的股价在公司获得高达2亿美元的私人配售后涨幅超过两倍，最新涨幅为163.2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"1129991095","title":"Minerva Neurosciences- 进一步可能获得4000万美元收益，与按现金行使B系列认股权证有关，取决于达成里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1129991095","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129991095?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048191,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences- 进一步可能获得4000万美元收益，与按现金行使B系列认股权证有关，取决于达成里程碑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"1159095091","title":"Minerva Neurosciences将扩大董事会规模并任命最多三位董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1159095091","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159095091?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048189,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences将扩大董事会规模并任命最多三位董事","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"1140588980","title":"Minerva Neurosciences - 预计将获得足够资金以支持Roluperidone的确认性3期试验及向FDA重新提交NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1140588980","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140588980?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048187,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences - 预计将获得足够资金以支持Roluperidone的确认性3期试验及向FDA重新提交NDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"1186159233","title":"Minerva Neurosciences宣布融资最高达2亿美元以推进Roluperidone治疗精神分裂症患者的负面症状，进行三期确认试验，并重新提交新药申请，准备美国商业上市（如获批准）","url":"https://stock-news.laohu8.com/highlight/detail?id=1186159233","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186159233?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:01","pubTimestamp":1761048071,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences宣布融资最高达2亿美元，以推进Roluperidone治疗精神分裂症患者负面症状的三期确认试验，并重新提交新药申请，准备在美国上市（如获批准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2574176172","title":"Minerva Neurosciences, Inc盘中异动 早盘大幅下挫7.77%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574176172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574176172?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:32","pubTimestamp":1760016720,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时32分，Minerva Neurosciences, Inc股票出现波动，股价急速下挫7.77%。截至发稿，该股报2.61美元/股，成交量6.7083万股，换手率0.96%，振幅1.41%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Turn Therapeutics Inc.、Galecto, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Cdt Equity Inc.、Alaunos Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1618.06%、930.18%、635.88%，振幅较大的相关个股有Turn Therapeutics Inc.、Galecto, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为42.86%、22.06%、12.08%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213200a458601c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213200a458601c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2561619231","title":"Minerva Neurosciences, Inc2025财年第二财季实现净利润-3.26百万美元，同比增加60.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561619231","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561619231?lang=zh_cn&edition=full","pubTime":"2025-08-23 00:01","pubTimestamp":1755878475,"startTime":"0","endTime":"0","summary":"8月23日，Minerva Neurosciences, Inc公布财报，公告显示公司2025财年第二财季净利润为-3.26百万美元，同比增加60.39%；其中营业收入为0.00美元，每股基本收益为-0.43美元。机构评级：截至2025年8月23日，当前有1家机构对Minerva Neurosciences, Inc目标价做出预测，其中目标均价为5.00美元，其中最低目标价为5.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250823000254a498e712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250823000254a498e712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV"],"gpt_icon":0},{"id":"2555506381","title":"Minerva Neurosciences, Inc盘中异动 股价大跌6.67%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555506381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555506381?lang=zh_cn&edition=full","pubTime":"2025-07-30 00:24","pubTimestamp":1753806277,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日00时24分，Minerva Neurosciences, Inc股票出现波动，股价大幅跳水6.67%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Calidi Biotherapeutics, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5411.41%、3519.22%、1685.73%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为161.91%、111.54%、75.60%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073000243794c1e9a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073000243794c1e9a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2551121674","title":"Minerva Neurosciences, Inc盘中异动 快速拉升5.87%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551121674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551121674?lang=zh_cn&edition=full","pubTime":"2025-07-16 23:49","pubTimestamp":1752680977,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日23时49分，Minerva Neurosciences, Inc股票出现波动，股价急速拉升5.87%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，知临集团、Barinthus Biotherapeutics Plc、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Qualigen Therapeutics, Inc.、知临集团、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为2775.34%、1737.97%、1078.03%，振幅较大的相关个股有知临集团、Barinthus Biotherapeutics Plc、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为334.61%、174.51%、77.54%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071623493797a8a09c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071623493797a8a09c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2551518741","title":"Minerva Neurosciences, Inc盘中异动 快速上涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551518741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551518741?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:22","pubTimestamp":1752506565,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时22分，Minerva Neurosciences, Inc股票出现异动，股价快速拉升5.70%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1989.13%、1040.05%、639.39%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为210.04%、197.81%、168.09%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507142322459542451f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507142322459542451f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2550650024","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.04%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650024?lang=zh_cn&edition=full","pubTime":"2025-07-10 03:13","pubTimestamp":1752088416,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日03时13分，Minerva Neurosciences, Inc股票出现异动，股价快速拉升5.04%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.41%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1886.82%、769.29%、642.34%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Nucana Plc，振幅分别为262.87%、154.98%、130.04%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710031337a440df36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710031337a440df36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2549352346","title":"Minerva Neurosciences, Inc盘中异动 股价大涨10.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549352346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549352346?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:00","pubTimestamp":1751983202,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时00分，Minerva Neurosciences, Inc股票出现波动，股价急速上涨10.36%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Prokidney Corp.、Rallybio Corporation、Moleculin Biotech, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Rallybio Corporation、Plus Therapeutics, Inc.较为活跃，换手率分别为844.38%、225.61%、147.32%，振幅较大的相关个股有Moleculin Biotech, Inc.、Prokidney Corp.、Rallybio Corporation，振幅分别为69.44%、62.64%、59.87%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708220002a43e3c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708220002a43e3c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2549919530","title":"Minerva Neurosciences, Inc盘中异动 早盘股价大涨8.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549919530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549919530?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:31","pubTimestamp":1751895097,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时31分，Minerva Neurosciences, Inc股票出现波动，股价急速上涨8.48%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为1369.26%、744.45%、656.15%，振幅较大的相关个股有Nucana Plc、Exicure, Inc.、Mustang Bio, Inc.，振幅分别为11.94%、9.29%、6.30%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213138a69b195c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213138a69b195c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2518003352","title":"Minerva Neurosciences, Inc盘中异动 大幅跳水6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518003352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518003352?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:15","pubTimestamp":1741634146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时15分，Minerva Neurosciences, Inc股票出现波动，股价急速下跌6.10%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6302.04%、3861.36%、1023.87%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031546a26aa67f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031546a26aa67f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2517369928","title":"Minerva Neurosciences, Inc盘中异动 快速上涨5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517369928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517369928?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:17","pubTimestamp":1741198670,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时17分，Minerva Neurosciences, Inc股票出现异动，股价急速拉升5.06%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为948.37%、305.84%、301.30%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021750989d778e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021750989d778e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2516753670","title":"Minerva Neurosciences, Inc盘中异动 急速下挫7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516753670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516753670?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:53","pubTimestamp":1741099982,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时53分，Minerva Neurosciences, Inc股票出现异动，股价大幅跳水7.19%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1138.13%、1114.47%、515.66%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Nutriband Inc C/Wts ，振幅分别为44.32%、37.67%、25.66%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225302abe7f68c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225302abe7f68c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2516552277","title":"Minerva Neurosciences, Inc2024财年实现净利润1.44百万美元，同比增加104.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552277?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:00","pubTimestamp":1740844851,"startTime":"0","endTime":"0","summary":"3月2日，Minerva Neurosciences, Inc公布财报，公告显示公司2024财年净利润为1.44百万美元，同比增加104.80%；其中营业收入为0.00美元，每股基本收益为0.19美元。从资产负债表来看，Minerva Neurosciences, Inc总负债62.84百万美元，其中短期债务0.00美元，资产负债比为0.60，流动比率为7.85。机构评级：截至2025年3月2日，当前有1家机构对Minerva Neurosciences, Inc目标价做出预测，其中目标均价为5.00美元，其中最低目标价为5.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104a259dc8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104a259dc8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minervaneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.9073},{"period":"6month","weight":1.1868},{"period":"1year","weight":0.8426},{"period":"ytd","weight":0.7915}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Minerva Neurosciences, Inc.在Cyrenaic制药公司的名义下根据特拉华州法律于2007年4月23日成立。2013年11月，它合并了Sonkei制药有限公司以及合并后的公司更名为密涅瓦神经科学有限公司。作为合并，或Sonkei合并的结果，该公司有权在全球范围内开发，销售和进口MIN- 101和MIN -117，根据与三菱田边制药公司许可协议的权利，不包括亚洲大部分地区。公司通过收购Mind-NRG SA（或Mind-NRG）的股份，在2014年2月进一步扩大其产品候选组合，它具有独家开发和商业化MIN- 301，或 Mind-NRG 收购的权利。公司是一家临床阶段的生物制药公司，专注于发展和商业化候选产品的组合来治疗病人中枢神经系统（或 CNS）疾病。公司的主导候选产品是MIN- 101——它正在开发用于治疗精神分裂症的治疗化合物，和MIN -117 ——公司正在开发用于治疗重性抑郁障碍的痛苦治疗化合物（或MDD ）。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.088598},{"month":2,"riseRate":0.181818,"avgChangeRate":-0.124863},{"month":3,"riseRate":0.363636,"avgChangeRate":0.000941},{"month":4,"riseRate":0.454545,"avgChangeRate":0.050114},{"month":5,"riseRate":0.545455,"avgChangeRate":0.1467},{"month":6,"riseRate":0.636364,"avgChangeRate":0.069702},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.035509},{"month":8,"riseRate":0.5,"avgChangeRate":0.304921},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003875},{"month":10,"riseRate":0.25,"avgChangeRate":-0.122814},{"month":11,"riseRate":0.5,"avgChangeRate":0.078313},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.080073}],"exchange":"NASDAQ","name":"Minerva Neurosciences","nameEN":"Minerva Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Minerva Neurosciences,NERV,Minerva Neurosciences股票,Minerva Neurosciences股票老虎,Minerva Neurosciences股票老虎国际,Minerva Neurosciences行情,Minerva Neurosciences股票行情,Minerva Neurosciences股价,Minerva Neurosciences股市,Minerva Neurosciences股票价格,Minerva Neurosciences股票交易,Minerva Neurosciences股票购买,Minerva Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}